Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIIITH MYELOMATOSIS TRIAL
NCT00002653Phase 3Unknown
- Sponsor
- Medical Research Council
- Start
- Sep 1993
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cyclophosphamide and prednisone in multiple myeloma (MM) (2 arms), sponsored by Medical Research Council. Status: unknown.
02
Drugs
cyclophosphamideprednisone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00002653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002653.